Factors Affecting Tamoxifen Metabolism in Patients With Breast Cancer: Preliminary Results of the French PHACS Study - Alicja Puszkiel, Cécile Arellano, Christelle Vachoux, Alexandre Evrard, Valérie Le Morvan, Jean‐Christophe Boyer, Jacques Robert, Caroline Delmas, Florence Dalenc, Marc Debled, Laurence Venat‐Bouvet, William Jacot, Etienne Suc, Isabelle Sillet‐Bach, Thomas Filleron - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

Published in

Wiley, Clinical Pharmacology & Therapeutics, 3(106), p. 585-595, 2019

DOI: 10.1002/cpt.1404

Links

ORCID
Wiley | PDF

Tools

Export citation

Search in Google Scholar

Factors Affecting Tamoxifen Metabolism in Patients With Breast Cancer: Preliminary Results of the French PHACS Study

Journal article published in 2019 by Alicja Puszkiel, Cécile Arellano, Christelle Vachoux, Alexandre Evrard, Valérie Le Morvan, Jean‐Christophe Boyer, Jacques Robert, Caroline Delmas, Florence Dalenc, Marc Debled, Laurence Venat‐Bouvet, William Jacot, Etienne Suc, Isabelle Sillet‐Bach, Thomas Filleron and other authors.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Upload

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO